The U.S. National Cancer Institute (NCI) produces the Common Terminology Criteria for Adverse Events (CTCAE).
CTCAE aids the reporting of adverse events that occur to patients enrolled in cancer therapy clinical trials.
CTCAE is a standard classification and severity grading scale for adverse events in clinical trials and oncology settings.
CTCAE corresponds with MedDRA at its Adverse Event level. Information systems can integrate CTCAE to exchange safety data and to enable data management for collecting and analyzing adverse event data.
For other versions of CTCAE, see:
Metathesaurus Update Frequency
CTCAE is included annually as part of the NCI Thesaurus in the Metathesaurus.